Ocular Therapeutix Inc
Ownership
Ownership Structure
Who owns Ocular Therapeutix Inc (OCUL)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 84.1% of the shares are freely tradable; institutional investors hold 95.7%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| FMR Inc | 14.96 | 32,844,043 | +0.6 | 06/30/2026 |
| Deep Track Capital, LP | 8.96 | 19,686,282 | +0.0 | 06/30/2026 |
| BlackRock Inc | 8.82 | 19,376,555 | +20.1 | 06/30/2026 |
| venBio Select Advisor LLC | 5.71 | 12,540,000 | +1.8 | 06/30/2026 |
| SUMMER ROAD LLC | 5.56 | 12,208,296 | +2.8 | 06/30/2026 |
| VR Adviser, LLC | 4.71 | 10,346,926 | +0.0 | 06/30/2026 |
| Vanguard Capital Management, LLC | 4.02 | 8,832,595 | +1.3 | 06/30/2026 |
| T. Rowe Price Associates, Inc. | 3.47 | 7,623,533 | +29.3 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Fidelity Growth Company Fund | 4.42 | 9,704,363 | +0.0 | 08/31/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 3.03 | 6,662,646 | +0.4 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Dugel Pravin | See Remarks | 3,270,332 | 22,892,324 $ | Aug 24, 2026 | both |
| Notman Donald | Chief Operating Officer | 366,529 | 2,565,703 $ | Aug 31, 2026 | direct |
| Nayak Sanjay | Chief Strategy Officer | 326,898 | 2,288,286 $ | Aug 24, 2026 | direct |
| Heier Jeffrey S. | Chief Scientific Officer | 307,457 | 2,152,199 $ | Oct 2, 2026 | direct |
| Kaiser Peter | Chief Development Officer | 254,388 | 1,780,716 $ | Oct 2, 2026 | direct |
| Anderman Todd | Chief Legal Officer | 140,484 | 983,388 $ | Oct 8, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 8, 2026 | Anderman Todd | Chief Legal Officer | Sell | 11,984 | 7.29 | 87,363 |
| Oct 2, 2026 | Kaiser Peter | Chief Development Officer | Sell | 9,990 | 7.05 | 70,430 |
| Oct 2, 2026 | Heier Jeffrey S. | Chief Scientific Officer | Sell | 10,869 | 7.05 | 76,626 |
| Aug 31, 2026 | Notman Donald | Chief Operating Officer | Sell | 1,099 | 10.24 | 11,254 |
| Aug 25, 2026 | Dugel Pravin | See Remarks | Other | 50,092 | 0.00 | – |
| Aug 24, 2026 | Kaiser Peter | Chief Development Officer | Sell | 3,035 | 10.77 | 32,687 |
| Aug 24, 2026 | Nayak Sanjay | Chief Strategy Officer | Sell | 1,897 | 10.78 | 20,450 |
| Aug 24, 2026 | Heier Jeffrey S. | Chief Scientific Officer | Sell | 3,296 | 10.78 | 35,531 |
| Aug 24, 2026 | Dugel Pravin | See Remarks | Sell | 21,649 | 10.77 | 233,160 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.